Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
1.760
-0.010 (-0.57%)
Sep 6, 2024, 3:00 PM CST
Kangmei Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 794.97 | 1,057 | 1,507 | 2,419 | 552.34 | 501.2 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 5.88 | Upgrade
|
Trading Asset Securities | 0.07 | 0.08 | 0.12 | 0.52 | - | - | Upgrade
|
Cash & Short-Term Investments | 795.04 | 1,057 | 1,508 | 2,419 | 552.34 | 507.08 | Upgrade
|
Cash Growth | -37.80% | -29.91% | -37.68% | 337.98% | 8.93% | -72.37% | Upgrade
|
Accounts Receivable | 2,261 | 2,095 | 2,046 | 1,460 | 2,487 | 3,855 | Upgrade
|
Other Receivables | 904.9 | 874.44 | 888.79 | 1,052 | 9,559 | 10,618 | Upgrade
|
Receivables | 3,166 | 2,969 | 2,935 | 2,512 | 12,046 | 14,473 | Upgrade
|
Inventory | 2,887 | 2,644 | 2,751 | 3,195 | 5,709 | 31,408 | Upgrade
|
Prepaid Expenses | 0.04 | 0.69 | 0 | - | 0.01 | - | Upgrade
|
Other Current Assets | 145.83 | 139.28 | 190.85 | 158.8 | 234.39 | 625.09 | Upgrade
|
Total Current Assets | 6,994 | 6,810 | 7,384 | 8,285 | 18,541 | 47,013 | Upgrade
|
Property, Plant & Equipment | 3,738 | 3,875 | 4,180 | 4,642 | 9,603 | 11,409 | Upgrade
|
Long-Term Investments | 1.12 | 1.15 | 1.39 | 1 | 1 | 1.04 | Upgrade
|
Goodwill | 106.35 | 106.35 | 106.35 | 106.35 | 36.91 | 81.2 | Upgrade
|
Other Intangible Assets | 469.98 | 491.02 | 529.79 | 579.73 | 1,309 | 2,022 | Upgrade
|
Long-Term Deferred Tax Assets | 100.4 | 101.48 | 96.97 | 60.69 | 240.96 | 256.7 | Upgrade
|
Long-Term Deferred Charges | 61.48 | 66.47 | 86.71 | 110.22 | 111.57 | 244.23 | Upgrade
|
Other Long-Term Assets | 2,786 | 2,829 | 2,783 | 2,269 | 3,483 | 3,558 | Upgrade
|
Total Assets | 14,257 | 14,280 | 15,169 | 16,054 | 33,326 | 64,586 | Upgrade
|
Accounts Payable | 2,523 | 2,256 | 2,563 | 2,015 | 3,762 | 3,774 | Upgrade
|
Accrued Expenses | 521.26 | 873.71 | 1,328 | 1,134 | 2,066 | 934.9 | Upgrade
|
Short-Term Debt | 23.41 | 26.14 | 25.62 | 15.17 | 2,315 | 12,811 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | - | 5,113 | Upgrade
|
Current Portion of Leases | 36.28 | 40.71 | 39.12 | 36.89 | - | - | Upgrade
|
Current Income Taxes Payable | 26.09 | 24.74 | 26.2 | 140.5 | 112.15 | 125.79 | Upgrade
|
Current Unearned Revenue | 151.91 | 159.89 | 158.12 | 193.85 | 455.19 | - | Upgrade
|
Other Current Liabilities | 1,420 | 1,298 | 1,301 | 1,411 | 14,576 | 5,064 | Upgrade
|
Total Current Liabilities | 4,702 | 4,680 | 5,442 | 4,947 | 23,286 | 27,823 | Upgrade
|
Long-Term Debt | - | - | - | - | 19,415 | 15,010 | Upgrade
|
Long-Term Leases | 176.46 | 188.16 | 199.13 | 153.22 | - | - | Upgrade
|
Long-Term Unearned Revenue | 603.42 | 618.68 | 653.98 | 692.97 | 1,035 | 1,103 | Upgrade
|
Long-Term Deferred Tax Liabilities | 46.43 | 51.68 | 55.53 | - | 0.05 | 0.08 | Upgrade
|
Other Long-Term Liabilities | 1,629 | 1,661 | 1,835 | 293.02 | - | - | Upgrade
|
Total Liabilities | 7,157 | 7,200 | 8,185 | 6,086 | 43,736 | 43,935 | Upgrade
|
Common Stock | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | 4,974 | Upgrade
|
Additional Paid-In Capital | 18,783 | 18,783 | 18,783 | 18,783 | 11,576 | 11,553 | Upgrade
|
Retained Earnings | -24,360 | -24,375 | -24,478 | -21,790 | -29,706 | 1,368 | Upgrade
|
Treasury Stock | -1,224 | -1,225 | -1,222 | -932.82 | -343.6 | -343.6 | Upgrade
|
Comprensive Income & Other | 1.12 | 1.18 | 1.43 | 3.1 | -3.74 | -3.51 | Upgrade
|
Total Common Equity | 7,064 | 7,048 | 6,948 | 9,927 | -13,504 | 17,548 | Upgrade
|
Minority Interest | 35.75 | 32.89 | 35.43 | 41.92 | 126.47 | 135.72 | Upgrade
|
Shareholders' Equity | 7,100 | 7,080 | 6,984 | 9,968 | -10,410 | 20,651 | Upgrade
|
Total Liabilities & Equity | 14,257 | 14,280 | 15,169 | 16,054 | 33,326 | 64,586 | Upgrade
|
Total Debt | 236.15 | 255.01 | 263.87 | 205.29 | 21,730 | 32,934 | Upgrade
|
Net Cash (Debt) | 558.89 | 801.68 | 1,244 | 2,214 | -21,178 | -32,427 | Upgrade
|
Net Cash Growth | -45.57% | -35.54% | -43.82% | - | - | - | Upgrade
|
Net Cash Per Share | 0.05 | 0.08 | 0.09 | 0.16 | -1.53 | -6.57 | Upgrade
|
Filing Date Shares Outstanding | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | 4,974 | Upgrade
|
Total Common Shares Outstanding | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | 4,974 | Upgrade
|
Working Capital | 2,292 | 2,130 | 1,942 | 3,338 | -4,745 | 19,190 | Upgrade
|
Book Value Per Share | 0.51 | 0.51 | 0.50 | 0.72 | -2.71 | 3.53 | Upgrade
|
Tangible Book Value | 6,488 | 6,450 | 6,312 | 9,240 | -14,849 | 15,444 | Upgrade
|
Tangible Book Value Per Share | 0.47 | 0.47 | 0.46 | 0.67 | -2.99 | 3.11 | Upgrade
|
Buildings | 5,229 | 5,229 | 5,401 | 5,665 | 8,359 | 7,039 | Upgrade
|
Machinery | 1,167 | 820.08 | 826.65 | 1,206 | 2,799 | 3,530 | Upgrade
|
Construction In Progress | 172.64 | 210.56 | 215.5 | 263.65 | 1,630 | 3,714 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.